Country: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
PSEUDOEPHEDRINE HYDROCHLORIDE; IBUPROFEN; CHLORPHENIRAMINE MALEATE
VITA HEALTH PRODUCTS INC
M01AE51
IBUPROFEN, COMBINATIONS
30.0MG; 200.0MG; 2.0MG
TABLET
PSEUDOEPHEDRINE HYDROCHLORIDE 30.0MG; IBUPROFEN 200.0MG; CHLORPHENIRAMINE MALEATE 2.0MG
ORAL
10/20/24/72/100
OTC
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0349765001; AHFS:
APPROVED
2010-11-29
Page 1 of 69 PRODUCT MONOGRAPH COLD + SINUS PLUS Ibuprofen 200 mg, Pseudoephedrine Hydrochloride 30 mg and Chlorpheniramine Maleate 2 mg Tablets Analgesic/Antipyretic/Nasal Decongestant/Antihistamine Vita Health Products Inc. Date of Revision: 150 Beghin Avenue September 16, 2020 Winnipeg, Manitoba Canada, R2J 3W2 Control No.: 238538 Page 2 of 69 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .......................................................... 3 SUMMARY PRODUCT INFORMATION....................................................................... 3 INDICATIONS AND CLINICAL USE ............................................................................ 3 CONTRAINDICATIONS .................................................................................................. 3 WARNINGS AND PRECAUTIONS ................................................................................ 5 ADVERSE REACTIONS ................................................................................................ 12 DRUG INTERACTIONS ................................................................................................ 21 DOSAGE AND ADMINISTRATION ............................................................................ 25 OVERDOSAGE ............................................................................................................... 26 ACTION AND CLINICAL PHARMACOLOGY ........................................................... 29 STORAGE AND STABILITY ........................................................................................ 35 SPECIAL HANDLING INSTRUCTIONS ...................................................................... 35 DOSAGE FORMS, COMPOSITION AND PACKAGING............................................ 35 PART II: SCIENTIFIC INFORMATION ................................................................................ 36 PHARMACEUTICAL INFORMATION ........................................................................ 36 CLINICAL TRIALS ........................................ সম্পূর্ণ নথি পড়ুন